DEF 14A: BranchOut Food Sets 2025 Annual Meeting Agenda
Proxy Statement
BranchOut Food Inc. announced its 2025 Annual Meeting of Stockholders to address director elections, executive compensation, and auditor ratification, alongside significant related party financing details.
Summary
- The 2025 Annual Meeting of Stockholders will be held on December 30, 2025, to elect six directors, conduct a nonbinding advisory vote on executive compensation, and ratify M&K CPAS, PLLC as the independent registered public accountants for fiscal year 2025.
- The Board of Directors unanimously recommends voting FOR all proposals.
- As of the record date, November 3, 2025, there were 12,327,109 shares of common stock issued and outstanding, held by approximately 30 record holders.
- The company engaged in substantial related party financing in 2024, including a 12% Senior Secured Convertible Promissory Note of up to $3,400,000 and a 15% Senior Secured Promissory Note of $1,200,000 from Kaufman Kapital LLC.
- Existing Senior Note holders, including an affiliate of the CFO, benefited from an Omnibus Amendment that reduced warrant exercise prices from $2.00 to $1.00 and extended maturity dates from December 31, 2024, to December 31, 2025, incurring $89,949 in additional interest expense.
- Related parties, including the CEO and an affiliate of the CFO, participated in a unit offering in July and August 2024, purchasing $525,000 worth of units, which resulted in the issuance of 692,429 shares of common stock and warrants to purchase 865,536 shares.
Sentiment
Score: 4
Explanation: The filing is primarily procedural for an annual meeting, but the extensive related party transactions, high interest rates on debt, and the lack of an audit committee financial expert suggest underlying financial challenges and governance weaknesses. While the board is recommending all proposals, the details of the financing arrangements point to a less favorable financial position.
Positives
- The Board of Directors unanimously recommends voting FOR all proposals, indicating internal alignment on key governance matters.
- Four out of six director nominees are independent according to Nasdaq standards, contributing to board oversight.
- The company has established Audit, Compensation, and Nominating and Corporate Governance Committees, each operating under a written charter.
- A formal policy for related-person transactions has been adopted, requiring Audit Committee approval for future dealings to enhance transparency and oversight.
Negatives
- No member of the Audit Committee currently meets the qualifications of an 'audit committee financial expert' due to a resignation, and the company is actively seeking a candidate.
- Several executive officers and directors, including the CEO and CFO, along with significant beneficial owners, had late Section 16(a) reports filed during the fiscal year ended December 31, 2024.
- The company relies significantly on related party financing, including secured notes from Kaufman Kapital LLC at 12% and 15% interest, and from investors led by an affiliate of the CFO at 15% interest, which are high rates.
- An Omnibus Amendment to existing Senior Notes, involving an affiliate of the CFO, resulted in $89,949 of additional interest expense due to reduced warrant exercise prices and extended maturity dates.
Risks
- Significant reliance on related party financing could lead to potential conflicts of interest and may indicate challenges in securing capital from unaffiliated third parties on more favorable terms.
- The absence of an 'audit committee financial expert' on the Audit Committee could increase the risk of financial reporting errors or compliance issues.
- High interest rates (12% and 15%) on secured debt from related parties suggest a higher perceived risk profile for the company or limited access to conventional, lower-cost financing.
- The extension of maturity dates and elimination of principal payments until maturity for certain Senior Notes could signal liquidity challenges or a need to conserve cash.
- Potential for dilution of existing shareholders from the conversion of convertible notes and the exercise of warrants, particularly those issued to related parties.
Future Outlook
The company will hold its 2025 Annual Meeting of Stockholders to address key governance matters, including the election of directors, an advisory vote on executive compensation, and the ratification of its independent registered public accountants. The Board of Directors will consider stockholder concerns regarding executive compensation in future arrangements. The company is also actively seeking a qualified candidate to serve as an audit committee financial expert.
Management Comments
- "Your vote is important. Whether or not you plan to attend the Annual Meeting, we would like for your shares to be represented. Please vote as soon as possible via the Internet, telephone, or mail." (Eric Healy, CEO)
- "Given the current size of our Board of Directors and our company, as well as Mr. Healy's history and intimacy with our company, and the effective oversight role played by our independent directors, we believe our current board structure is appropriate for us and our stockholders." (Regarding combined CEO/Chairman role)
- "We believe that our compensation policies and procedures are intended to be aligned with the long-term interests of our stockholders." (Regarding executive compensation)
Industry Context
This proxy statement outlines standard corporate governance procedures for a publicly traded company, focusing on the annual meeting agenda. The significant related party financing and high interest rates suggest a company potentially in a growth phase or facing capital access challenges, which is not uncommon for smaller public companies in competitive consumer goods or food industries. The need for an audit committee financial expert highlights a common challenge for growing companies in meeting stringent regulatory requirements.
Comparison to Industry Standards
- The company's board structure, with the CEO also serving as Chairman and no lead independent director, deviates from a growing trend among larger public companies to separate these roles for enhanced independent oversight.
- The high interest rates (12-15%) on secured notes from related parties are significantly above typical corporate borrowing rates for established companies, suggesting a higher risk profile or limited access to conventional financing, which is common for early-stage or distressed companies.
- The absence of an 'audit committee financial expert' is a notable deviation from best practices for public companies, which typically strive to have such expertise to ensure robust financial oversight, as seen in companies like General Mills or Kellogg's.
- The related party transactions, while disclosed, are more extensive than typically seen in mature, well-capitalized public companies, which often seek to minimize such dealings to avoid perceived conflicts of interest.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | N/A | John Dalfonsi | 2024-01-10 | Appointment |
| Director | N/A | Byron Rich Jones | 2024-01-10 | Appointment |
| Director | N/A | Deven Jain | 2024-07-24 | Appointment upon closing of investment by Kaufman Kapital, LLC |
| Director | N/A | Lindsey L. Schwartz | 2025-02-13 | Appointment |
| Director | David Israel | N/A | 2025-10-09 | Resignation (now serves as a consultant) |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Audit Committee Composition | Due to Mr. Dalfonsi's resignation from the Audit Committee in January 2024, no member currently meets the qualifications of an audit committee financial expert. The company is seeking a candidate. | 2024-01-01 | Potential increase in financial reporting risk and compliance challenges until a qualified expert is appointed. |
| Related-Person Transactions Policy | Adopted a formal policy requiring all future related person transactions to be approved in advance by the Audit Committee. | N/A (policy adopted) | Aims to enhance transparency and oversight of related party dealings, potentially reducing conflicts of interest. |
Related Party Transactions
- On July 15, 2024, the company entered into a Securities Purchase Agreement with Daniel L. Kaufman (later replaced by Kaufman Kapital LLC) for a 12% Senior Secured Convertible Promissory Note of up to $3,400,000 and warrants to purchase 1,500,000 shares. Daniel L. Kaufman is the Managing Member of Kaufman Kapital LLC, which became a 34.5% beneficial owner.
- On August 30, 2024, the company borrowed $1,200,000 from Kaufman Kapital LLC via a Senior Secured Promissory Note at a 15% interest rate.
- An Omnibus Amendment to Note Documents reduced the exercise price of warrants from $2.00 to $1.00 and extended maturity dates for Senior Notes held by investors, including Eagle Vision Fund LP, an affiliate of CFO John Dalfonsi. This resulted in $89,949 of additional interest expense.
- From January to May 2024, the company sold $1,675,000 of Senior Secured Promissory Notes and Warrants to investors led by Eagle Vision Fund LP, an affiliate of CFO John Dalfonsi, at a 15% interest rate. Eagle Vision also received $177,500 in cash fees for services.
- On July 15, 2024, Eric Healy (CEO), Eagle Vision (CFO's affiliate), and the company's President purchased $525,000 of Units (common stock and warrants) in a private placement.
Stakeholder Impact
- Shareholders will vote on key governance matters, including director elections and executive compensation. Existing shareholders face potential dilution from convertible notes and warrants issued, particularly to related parties. The high interest rates on debt could impact future profitability and cash flow.
- Creditors (Kaufman Kapital, Eagle Vision-led investors) hold secured notes with high interest rates, indicating a significant financial commitment and risk exposure. Their liens on substantially all company assets provide security.
- Management/Directors: Executive compensation is subject to an advisory vote. Directors are up for re-election. Several directors and officers are involved in related party transactions, which could raise questions about conflicts of interest.
- Employees: No direct impact mentioned, but financial health and governance practices can indirectly affect employee morale and stability.
Next Steps
- Stockholders are to vote on the election of six directors, advisory approval of executive compensation, and ratification of M&K CPAS, PLLC as independent registered public accountants at the Annual Meeting.
- The company will announce preliminary voting results at the Annual Meeting and disclose final results on a Form 8-K within four business days.
- The company is actively seeking a qualified candidate to serve as an audit committee financial expert.
- The Board and Compensation Committee will consider stockholder feedback on executive compensation for future arrangements.
Key Dates
| Date | Description |
|---|---|
| 2017-11-01 | Eric Healy became Chief Executive Officer. |
| 2022-04-12 | Consulting agreement with John Dalfonsi (CFO) dated. |
| 2022-12-06 | Employment agreement with Eric Healy (CEO) dated. |
| 2023-06-01 | Approximate completion of the Company's initial public offering, when Eric Healy's annualized salary commenced. |
| 2023-06-21 | John Dalfonsi and Greg Somerville appointed as directors. |
| 2023-10-24 | John Dalfonsi granted 30,000 stock options. |
| 2023-12-31 | Fiscal year end for 2023 financial reporting. |
| 2024-01-09 | Start date for the sale of Senior Secured Promissory Notes and Warrants to Investors led by Eagle Vision Fund LP. |
| 2024-01-10 | John Dalfonsi appointed Chief Financial Officer; his consulting agreement was amended on this date to serve as CFO until December 31, 2025. Byron Rich Jones appointed to the Board of Directors. |
| 2024-02-22 | Eric Healy, John Dalfonsi, David Israel, Byron Rich Jones, and Greg Somerville were granted stock options. |
| 2024-02-28 | Options granted to Eric Healy and John Dalfonsi vested immediately. |
| 2024-05-22 | End date for the sale of Senior Secured Promissory Notes and Warrants to Investors led by Eagle Vision Fund LP. |
| 2024-06-21 | Warrants issued to the underwriter in the Company's initial public offering. |
| 2024-06-26 | Warrants issued to the underwriter in the Company's follow-on public offering. |
| 2024-07-15 | Company entered into a Securities Purchase Agreement with Daniel L. Kaufman for a Convertible Note and Warrants. Company also entered into Subscription Agreements with Eric Healy, Eagle Vision, and the Company's President for a Unit Offering. |
| 2024-07-19 | Amendment to the Securities Purchase Agreement, replacing Daniel L. Kaufman with Kaufman Kapital LLC as the Investor. |
| 2024-07-23 | Sale of Units to Eric Healy and the Company's President completed. |
| 2024-07-24 | Deven Jain appointed to the Board of Directors. Company issued Purchased Securities to Kaufman Kapital LLC. |
| 2024-08-30 | Company borrowed $1,200,000 from Kaufman Kapital LLC via a Senior Secured Promissory Note. Sale of Units to Eagle Vision completed. |
| 2024-12-09 | $1,400,000 balance on the Convertible Promissory Note received from Kaufman Kapital LLC. |
| 2024-12-31 | Fiscal year end for 2024 financial reporting. Maturity date for Senior Notes held by Holders (extended to Dec 31, 2025). |
| 2025-02-13 | Lindsey L. Schwartz appointed to the Board of Directors. |
| 2025-04-15 | Annual Report on Form 10-K for fiscal year ended December 31, 2024, filed with the SEC. |
| 2025-06-30 | Maturity date for the $1,200,000 Senior Secured Promissory Note from Kaufman Kapital LLC (as amended). |
| 2025-09-01 | Deven Jain became a portfolio manager at Z1 Labs (approximate). |
| 2025-10-01 | Greg Somerville became CEO of Maple Donuts, LLC (approximate). |
| 2025-10-09 | David Israel resigned as a director. |
| 2025-11-03 | Record date for the 2025 Annual Meeting of Stockholders. |
| 2025-11-17 | Notice of annual meeting, proxy statement, and form of proxy made available on or about this date. |
| 2025-12-29 | Deadline for voting by mail, Internet, or telephone for the Annual Meeting. |
| 2025-12-30 | 2025 Annual Meeting of Stockholders held. |
| 2025-12-31 | Maturity date for the 12% Senior Secured Convertible Promissory Note from Kaufman Kapital LLC. John Dalfonsi's term as CFO ends. |
| 2026-07-20 | Deadline for stockholder proposals for inclusion in the 2026 Annual Meeting proxy statement. |
Recommendation
holdThe filing is a proxy statement, not a financial results report, so a direct 'buy' or 'sell' based on performance is not appropriate. However, the significant reliance on high-interest related-party debt and the identified corporate governance weakness (lack of an audit committee financial expert) suggest caution. While the company is addressing standard annual meeting items, the financial arrangements indicate potential underlying challenges. A 'hold' recommendation allows investors to monitor how these financial and governance issues evolve and if the company can transition to more conventional financing and strengthen its board oversight.
Keywords
BranchOut Food, DEF 14A, Proxy Statement, Annual Meeting, Corporate Governance, Executive Compensation, Director Election, Auditor Ratification, Related Party Transactions, Convertible Notes, Warrants, SEC Filing, Stockholder Vote, Nasdaq Compliance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.